Ginkgo Bioworks Holdings (DNA) Other Working Capital Changes (2020 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Other Working Capital Changes of -$2.6 million for Q1 2026, up 80.84% on a QoQ basis from -$13.6 million in Q4 2025, and up 80.24% year-over-year from -$1.4 million in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 80.24% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.8 million (down 211.6% YoY) and the FY2025 annual result came in at -$32.4 million, down 1646.94% from the prior year.
- Other Working Capital Changes was -$2.6 million for Q1 2026 at Ginkgo Bioworks Holdings, up from -$13.6 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $13.8 million in Q4 2022 and bottomed at -$7.4 million in Q1 2023.
- A 5-year average of -$748117.6 and a median of -$1.2 million in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 13095.6% — and 2024, when it surged 1656.19%.
- Ginkgo Bioworks Holdings' Other Working Capital Changes stood at -$36.5 million in 2022, then surged by 87.7% to -$4.5 million in 2023, then jumped by 1656.19% to $69.9 million in 2024, then tumbled by 119.46% to -$13.6 million in 2025, then surged by 80.84% to -$2.6 million in 2026.
- Business Quant data shows DNA's Other Working Capital Changes at -$2.6 million in Q1 2026, -$13.6 million in Q4 2025, and $4.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.93 Mn |
| Mar 31, 2026 | -5.93 Mn |
| Mar 31, 2026 | -5.93 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Sep 30, 2025 | -2.20 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 581,000.00 |
| Mar 31, 2025 | 581,000.00 |
| Mar 31, 2025 | 581,000.00 |
| Dec 31, 2024 | -6.60 Mn |
| Dec 31, 2024 | -6.60 Mn |
| Dec 31, 2024 | -6.60 Mn |
| Sep 30, 2024 | -1.72 Mn |
| Sep 30, 2024 | -1.72 Mn |